Pharma-Bio Serv (OTCMKTS:PBSV) Stock Passes Below Two Hundred Day Moving Average of $0.91

Pharma-Bio Serv, Inc. (OTCMKTS:PBSV) crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.91 and traded as low as $0.74. Pharma-Bio Serv shares last traded at $0.74, with a volume of 5,317 shares trading hands.

Pharma-Bio Serv Price Performance

The company’s 50 day moving average is $0.85 and its 200 day moving average is $0.91. The stock has a market cap of $16.88 million, a price-to-earnings ratio of 24.51 and a beta of 0.51.

Pharma-Bio Serv (OTCMKTS:PBSV) last announced its earnings results on Monday, March 18th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.03). The business had revenue of $2.38 million for the quarter, compared to analyst estimates of $5.00 million. Pharma-Bio Serv had a return on equity of 3.95% and a net margin of 4.05%. Sell-side analysts predict that Pharma-Bio Serv, Inc. will post 0.08 earnings per share for the current year.

Pharma-Bio Serv Company Profile

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.